wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37847070-2CCB0AAF-66F1-4224-83AE-29CE28CD949D
Q37847070-2CCB0AAF-66F1-4224-83AE-29CE28CD949D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37847070-2CCB0AAF-66F1-4224-83AE-29CE28CD949D
Targeting angiogenesis from multiple pathways simultaneously: BIBF 1120, an investigational novel triple angiokinase inhibitor.
P2860
Q37847070-2CCB0AAF-66F1-4224-83AE-29CE28CD949D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37847070-2CCB0AAF-66F1-4224-83AE-29CE28CD949D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d97dcbfb7c5ca940b19db63766f834ae05026b81
P2860
Vandetanib versus gefitinib in patients with advanced non-small-cell lung cancer: results from a two-part, double-blind, randomized phase ii study.